Share
Journal Information
Issue
Vol. 15. Issue 4.Pages 221-296 (October - December 2022)
Editorial
Here we go again! Subtyping diagnosis and refining treatments
Javier Vázquez-Bourgon
Rev Psiquiatr Salud Ment. 2022;15:221-2
Open access
Open Article
Originales
Risk factors of deficit and non-deficit schizophrenia: Results from a cross-sectional study
Agnieszka Cyran, Patryk Piotrowski, Jerzy Samochowiec, Tomasz Grąźlewski, Błażej Misiak
Rev Psiquiatr Salud Ment. 2022;15:223-9
Full text access
Open Article
Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiency
Miguel Bernardo, Gisela Mezquida, Paula Ferré, Bibiana Cabrera, Mercè Torra, Ana Maria Lizana, Mercè Brunet
Rev Psiquiatr Salud Ment. 2022;15:230-7
Full text access
Open Article
Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries
Carlos De las Cuevas, Emilio J. Sanz, Can-Jun Ruan, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:238-50
Full text access
Open Article
Clinical symptoms and social functioning in schizophrenia
Maria Jose Escandell, Gemma Prat, Mar Garcia-Franco, Jose Ramón Martín-Martínez, Susana Ochoa, Ingrid Tortades, Sonia Vilamala, Marina Verdaguer-Rodríguez, Emma Casas-Anguera
Rev Psiquiatr Salud Ment. 2022;15:251-8
Full text access
Open Article
Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI)
Esther Lorente-Rovira, Eva Grasa, Susana Ochoa, Iluminada Corripio, Trinidad Peláez, Raquel López-Carrilero, Ángela Gutiérrez-Gea, María Morano-Guillén, ... Julio Sanjuán
Rev Psiquiatr Salud Ment. 2022;15:259-71
Full text access
Open Article
Estabilidad diagnóstica en la psicosis inducida por sustancias
Lucía Inchausti, Iñigo Gorostiza, Miguel Angel Gonzalez Torres, Rodrigo Oraa
Rev Psiquiatr Salud Ment. 2022;15:272-80
Full text access
Open Article
Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series
Aygün Ertuğrul, A. Elif Anıl Yağcıoğlu, Esen Ağaoğlu, Ahmet Alp Karakaşlı, Sertaç Ak, M. Kâzım Yazıcı, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:281-6
Full text access
Open Article
Cartas al director
Clozapine for the treatment of pediatric encephalopathy associated with nonketotic hyperglycinemia
Sara Jiménez-Fernández, Manuel Gurpegui, Jose de Leon, Luis Gutiérrez-Rojas
Rev Psiquiatr Salud Ment. 2022;15:287-9
Full text access
Open Article
A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels
Manuel Arrojo-Romero, Maria Rosario Codesido-Barcala, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:290-2
Full text access
Open Article
A clozapine's uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agency
Pilar Andres-Olivera, Concha Turrion, Emilio Fernandez-Egea, Jesus Perez
Rev Psiquiatr Salud Ment. 2022;15:293-4
Full text access
Open Article
Clozapine-induced myocarditis in Russia: Animal studies but no clinical studies
Oleg O. Kirilochev, Carlos De las Cuevas, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:294-5
Full text access
Open Article